🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

Firefly Neuroscience, Inc. AIFF TECHAI

Technology · Software - Application · United States
https://fireflyneuro.com
Company Profile ↓
$1.11
-60.78% 1Y
Mkt Cap$17.42M
P/E-2.18
P/B1.13
52W High$3.05
52W Low$0.64
Book Value$0.94
EPS (TTM)$-0.51

Company Overview

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Recent Developments

  • Dec 2025 Revenue of $1.14M (+957.4% YoY); net profit $-19.88M.
  • Trailing 12 Months Year-on-year growth — revenue +71.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR -11.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-11.27%
1 Year:71.90%

Stock Price Performance

1 Year:-60.78%
6 Months:-33.53%
3 Months:-30.63%
1 Month:-7.50%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 20% of range
$0.64 $3.05
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)49.68 · Neutral
Price Performance
1M-7.50%
3M-30.63%
6M-33.53%
1Y-60.78%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -11.3% CAGR over 5 years.
  • Trading 63.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-2.18
Industry PE
29.22
Forward P/E
-
PEG Ratio
-
Book Value
$0.94
Price to Book
1.13
P/S
9.24
EV/EBITDA
-0.94
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-11.27%
Profit 5Y
-
Revenue (YoY)
71.90%
Earnings (YoY)
-

Profitability & Returns

ROCE
-115.64%
ROE
-68.06%
ROA
-34.85%
Profit Margin
0.00%
Op Margin
-
Gross Margin
44.58%
EPS (Latest Qtr)
$-0.20
EPS (TTM)
$-0.51

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
4.49
Current Ratio
4.87
Debt
$0
Total Assets
$10.91M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
28.12%
Chg in Prom Hold
-0.15%
FII / Inst Holding
10.46%
Chg in FII Hold
0.16%

Financial Snapshot

Enterprise Value
$17.42M
Total Revenue (TTM)
$1.80M
EBITDA
$-8.72M
Free Cash Flow
$-4.41M
Operating Cash Flow
$-6.99M
Shares Outstanding
15.69M
Gross Margin
44.58%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Technology).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 AIFF Firefly Neuroscience, Inc. TECHAI 1.11 -2.18 $17.42M 0.00% -115.64% -68.06% -11.27% -
2 NVDA NVIDIA Corporation NDXSPXR3KAITECH 225.73 28.50 $5.45T 0.46% 74.66% 117.21% 24.64% 32.12%
3 AAPL Apple Inc. NDXSPXR3KTECH 316.22 36.22 $4.61T 0.34% 68.72% 148.75% 1.81% 3.92%
4 MSFT Microsoft Corporation NDXSPXR3KAITECH 493.95 27.49 $3.67T 0.79% 26.33% 34.04% 9.93% 11.90%
5 TSM Taiwan Semiconductor Manufacturing Company Limited AITECH 439.00 32.71 $2.28T 0.95% 30.20% 39.97% 18.94% 19.57%
6 AVGO Broadcom Inc. NDXSPXR3KAITECH 368.56 46.95 $1.75T 0.71% 16.70% 44.25% 17.04% 54.08%
7 MU Micron Technology, Inc. NDXSPXR3KAITECH 1,000.26 22.59 $1.13T 0.05% 13.69% 66.64% 13.68% 26.02%
8 AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH 505.74 128.36 $825.61B 0.00% 5.47% 10.20% 11.81% 66.28%
9 ASML ASML Holding N.V. NDXAITECH 1,764.85 59.89 $677.88B 0.51% 42.97% 53.94% 15.55% 19.55%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2013Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue 1.32M1.12M3.22M1.18M1.02M1.36M1.48M1.31M1.46M1.47M1.82M2.03M1.48M4.06M2.73M1.39M3.71M2.42M1.18M3.70M---------2.31M--23.00K12.00K10.00K33.00K43.00K299.00K388.00K485.00K
Gross Profit 513.06K403.39K755.52K454.28K317.17K604.15K484.25K436.20K444.26K357.67K525.75K556.09K499.85K637.34K635.89K550.42K555.35K569.11K322.84K356.76K384.32K278.83K389.02K614.33K1.02M955.93K978.88K696.47K903.84K738.60K656.80K705.01K649.81K699.26K10.00K33.00K43.00K274.00K146.00K221.00K
Operating Income -53.52K-138.45K105.72K-100.22K-163.90K25.55K-87.31K-98.26K-100.33K-212.70K-148.12K-59.80K-33.57K86.52K108.00K-35.95K-8.87K25.09K-193.56K-211.63K-181.74K-127.61K-34.45K214.91K268.87K53.98K-84.27K-1.68M-1.60M-1.13M-954.73K493.12K-647.00K-1.09M-1.26M-4.27M-2.06M-1.63M-2.66M-2.01M
Net Income -52.14K-136.52K108.37K-97.52K-161.30K27.99K-84.83K-95.65K-97.74K-210.27K-145.76K-57.24K-31.62K88.72K110.28K-33.28K-5.88K27.96K-190.85K-208.60K-179.22K-126.34K-34.62K214.70K270.81K43.16K-95.53K-2.08M-1.53M-4.70M-1.35M234.78K-650.00K-1.12M-1.26M-4.29M-12.93M-1.83M-2.64M-2.00M
Diluted EPS 0.00-0.010.01-0.01-0.010.00-0.01-0.01-0.01-0.02-0.01-0.010.000.010.010.000.000.00-0.02-0.02-0.02-0.010.000.020.020.00-0.01-0.12-0.09-0.26-0.36---0.58-0.61---0.20-
R&D Expense --------------------------------392.00K289.00K350.00K878.00K312.00K336.00K378.00K424.00K

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 6.86M7.82M7.06M7.48M5.78M6.21M6.73M10.64M8.93M10.16M13.90M15.03M12.02M498.00K108.00K1.14M
Gross Profit 2.39M2.44M2.41M2.26M2.39M2.37M1.82M2.42M2.14M1.40M2.21M3.62M2.86M2.61M108.00K645.00K
Operating Income 136.93K148.81K94.13K-69.23K-39.83K68.12K-563.45K237.77K-62.34K-727.79K411.85K-2.63M-5.42M-3.08M-10.05M-8.86M
Net Income 146.46K153.40K100.42K-60.24K-29.79K78.33K-553.68K246.46K-51.03K-717.25K413.38K-1.13M-17.75M-2.60M-10.46M-19.88M
Diluted EPS 0.010.010.01-0.010.000.01-0.050.020.00-0.060.03-0.09----
R&D Expense -------------741.00K1.95M1.48M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -3.37M5.02M3.60M4.41M4.25M4.12M3.75M3.73M3.02M2.37M3.77M23.36M7.98M2.64M4.60M10.48M
Total Equity 1.72M1.88M2.04M2.15M2.11M2.09M2.18M1.63M1.89M1.87M1.16M1.61M17.44M-2.23M109.00K-375.00K7.64M
Cash & Equivalents 1.48M1.97M1.28M2.62M2.36M2.45M2.17M1.90M2.73M1.96M1.04M1.86M4.93M731.08K682.00K--
Long Term Debt -----------356.99K-----
Total Liabilities ---1.46M2.30M2.16M1.94M2.12M1.84M1.15M1.21M2.16M5.92M4.25M2.53M4.98M2.84M
Current Liabilities -1.49M2.98M1.46M-----1.15M1.17M1.80M1.98M3.89M2.53M4.98M2.82M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 529.14K-669.39K1.36M-215.66K116.68K-264.98K-256.51K836.07K-763.50K-917.15K423.26K--2.89M-2.17M-6.16M-8.19M
Investing Cash Flow -22.18K-17.76K-21.59K-47.83K-26.20K-17.09K-16.05K71-4.05K-8.37K-64.55K-262.00K-386.00K-477.00K-2.49M
Financing Cash Flow -17.39K6.44K3500-----1.00K460.00K-2.04M4.64M6.30M11.62M
Capital Expenditure -22.18K-24.20K-26.25K-39.16K-32.16K-18.23K-13.42K-840-5.77K-8.37K-64.55K---386.00K-415.00K-128.00K
Free Cash Flow 506.97K-693.59K1.34M-254.82K84.52K-283.21K-269.93K835.23K-769.27K-925.51K358.72K--2.89M-2.56M-6.57M-8.32M
Net Change in Cash -------------595.00K2.08M-333.00K937.00K

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 34.8%31.2%34.2%30.2%41.3%38.2%27.1%22.7%24.0%13.8%15.9%24.1%23.8%525.0%100.0%56.5%
Operating Margin % 2.0%1.9%1.3%-0.9%-0.7%1.1%-8.4%2.2%-0.7%-7.2%3.0%-17.5%-45.1%-618.1%-9,309.3%-775.5%
Net Margin % 2.1%2.0%1.4%-0.8%-0.5%1.3%-8.2%2.3%-0.6%-7.1%3.0%-7.5%-147.7%-522.7%-9,685.2%-1,741.0%
ROE % 7.8%7.5%4.7%-2.9%-1.4%3.6%-33.9%13.0%-2.7%-61.7%25.6%-6.5%797.6%-2,388.1%2,789.3%-260.3%
ROCE % 7.3%7.3%4.4%------3.3%-60.2%20.9%-12.3%-132.4%-2,823.9%2,681.1%-115.6%

Shareholding Pattern

Insiders
28.12%
Institutions
10.46%
Public Float
14.55%

Top Institutional Holders

#Holder% HeldSharesValue
1 Murchinson Ltd. 4.14% 650.00K $819.00K
2 Blackrock Inc. 1.19% 187.17K $235.83K
3 Boothbay Fund Management, LLC 1.14% 178.75K $225.22K
4 Geode Capital Management, LLC 0.77% 121.52K $153.12K
5 Vanguard Capital Management LLC 0.71% 111.91K $141.01K
6 Jane Street Group, LLC 0.43% 67.83K $85.46K
7 UBS Group AG 0.38% 59.12K $74.49K
8 Vanguard Fiduciary Trust Co 0.32% 50.99K $64.25K
9 State Street Corporation 0.30% 46.30K $58.34K
10 Cygnus Capital Advisors, LLC 0.28% 44.55K $56.13K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AIFF

Yahoo Finance Wed, 05 Aug 2026

Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

Commercial momentum continues to build, while Firefly harnesses increased electrophysiological data combining EEG and ERG to unlock future valueKENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “C…

Yahoo Finance ue, 28 Jul 2026

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their potential neuroprotective…

Yahoo Finance ue, 02 Jun 2026

Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War – KENMORE, N.Y, June 02, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Ar…

Yahoo Finance Mon, 13 Apr 2026

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

- Firefly’s total brain scan volumes have increased sequentially by higher percentages in each of the past four quarters - - Firefly is harnessing increased data and NVIDIA L40S GPU acceleration to power next-generation EEG/ERP processing, …

Yahoo Finance hu, 26 Mar 2026

Firefly Confirms Public-Private Partnership with the Department of War

Firefly’s AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of Company’s Commercial Footprint into the U.S…

Yahoo Finance Fri, 13 Mar 2026

Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD

Over 22 million Americans are diagnosed with ADHD — yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly’s AI-powered EEG/ERP technology may help identify which AD…

AIFF — Frequently Asked Questions

What is the current share price of Firefly Neuroscience, Inc. (AIFF)?

As of 2026-09-19 21:16 PDT, Firefly Neuroscience, Inc. (AIFF) trades at $1.11 on NasdaqCM. Its 52-week range is $0.64 to $3.05.

What is the market capitalisation of AIFF?

Firefly Neuroscience, Inc. (AIFF) has a market capitalisation of $17.42M on NasdaqCM.

What is the P/E ratio of AIFF?

AIFF trades at a trailing price-to-earnings (P/E) ratio of -2.18. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 1.13.

What is the return on equity (ROE) of AIFF?

AIFF has a return on equity (ROE) of -68.06%. Its return on capital employed (ROCE) is -115.64%.

Is AIFF a good stock to buy?

This page provides a data-driven analysis of Firefly Neuroscience, Inc. (AIFF), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Technology Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space